脓毒症经验性抗生素治疗:保护厌氧菌群
本文为观点文章,讨论脓毒症经验性抗生素治疗中抗厌氧菌覆盖的必要性有限。厌氧菌极少是脓毒症致病菌,但抗厌氧菌抗生素使用频繁。多项研究显示,抗厌氧菌抗生素耗竭肠道厌氧共生菌影响全身免疫,与脓毒症患者死亡率增加相关。作者主张提高厌氧菌意识,减少脓毒症经验性治疗中不必要的抗厌氧菌抗生素使用以改善预后。
要点
- 厌氧菌极少是脓毒症的致病病原体,但抗厌氧菌抗生素仍被频繁使用。
- 多项研究显示,抗厌氧菌抗生素耗竭肠道厌氧共生菌会影响全身免疫,并与脓毒症患者死亡率增加相关。
- 这一认知尚未转化为临床实践,多数医生在脓毒症经验性覆盖厌氧病原体时倾向于「安全胜于遗憾」。
- 作者认为抗厌氧菌抗生素常导致「遗憾」而非「安全」,应减少脓毒症经验性治疗中不必要的抗厌氧菌抗生素使用。
适用人群与场景
- 脓毒症患者,处于经验性抗生素治疗阶段。
研究设计与关键结果
- 本文为观点文章,未报告原始研究数据。
- 文中汇总:厌氧菌极少为脓毒症致病病原体;抗厌氧菌抗生素使用频繁,可能带来非预期后果。
- 文中汇总:多项研究显示抗厌氧菌抗生素耗竭肠道厌氧共生菌影响全身免疫,与脓毒症患者死亡率增加相关。
证据类型、等级与局限
- 证据类型:观点文章(Viewpoint)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,抗厌氧菌抗生素常导致「遗憾」而非「安全」,应减少脓毒症经验性治疗中不必要的抗厌氧菌抗生素使用以改善预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Antibiotics are fundamental in sepsis management; however, the optimal empirical treatment remains debated. Despite anaerobes rarely being the causative pathogen of sepsis, antibiotics targeting them are frequently used, which might lead to unintended consequences. Multiple studies have shown that depletion of commensal anaerobic gut microbes by anti-anaerobic antibiotics influences systemic immunity and is associated with increased mortality in patients with sepsis. However, this knowledge has not yet been translated into clinical practice. When considering empirical coverage of anaerobic pathogens in sepsis, most physicians advocate for a better-safe-than-sorry approach. In this Viewpoint, we argue that anti-anaerobic antibiotics could often result in being sorry rather than safe. We provide an overview of the limited necessity of anaerobic coverage and the potential detrimental effects of anaerobic depletion in sepsis. We aim to raise anaerobic awareness to reduce the unnecessary use of anti-anaerobic antibiotics in empirical sepsis treatment and improve patient outcomes.
参考来源
- Kullberg RFJ, Haak BW, Chanderraj R, et al. Empirical antibiotic therapy for sepsis: save the anaerobic microbiota. Lancet Respir Med. 2024. PMID: 39401510. doi:10.1016/S2213-2600(24)00257-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。